PHAEUROPE shared a post on LinkedIn:
“Crown Princess Mette‑Marit raises awareness of serious lung disease
Crown Princess Mette‑Marit of Norway has bravely shared that her progressive lung fibrosis has advanced, and her doctors are now preparing her for the possibility of a lung transplant. Lung fibrosis is part of a broader group of diseases known as interstitial lung diseases (ILDs), which in some cases can lead to pulmonary hypertension (PH‑ILD), significantly worsening symptoms and prognosis.
By speaking publicly, the Crown Princess is helping to raise awareness, reduce stigma, and encourage early diagnosis and care for patients with rare and life‑impacting lung conditions.
In recent years, research into treatments for lung fibrosis and PH‑ILD has intensified. Several clinical trials are exploring therapies aimed at slowing disease progression, improving symptoms, and enhancing quality of life. Despite these advances, for some patients with advanced disease, medical treatments may not be sufficient or may not become available in time, leaving lung transplantation as the only viable option. This is a major, life-changing procedure, reserved for carefully selected patients and performed in highly specialised centres.
We extend our sincere respect and best wishes to Crown Princess Mette‑Marit and her family as she faces a demanding period ahead. Her story is a powerful reminder of why continued investment in research, patient support, and international collaboration in lung disease and pulmonary hypertension remains so vital.
Read full article.”
You can also read: Teresa Barnes on Crown Princess Mette-Marit’s Story and the Fight for a Cure for Pulmonary Fibrosis